 HOLON, Israel, Dec. 23, 2020 PRNewswire -- Compugen Ltd. NASDAQ: CGEN, a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today progress from its ongoing license agreement with AstraZeneca LSE: AZN STO: AZN NASDAQ: AZN under... 